✦ LIBER ✦

The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo-controlled, Phase III study in patients with myelofibrosis

✍ Scribed by Verstovsek, Srdan; Mesa, Ruben A.; Gotlib, Jason; Levy, Richard S.; Gupta, Vikas; DiPersio, John F.; Catalano, John V.; Deininger, Michael; Miller, Carole; Silver, Richard T.; Talpaz, Moshe; Winton, Elliott F.; Harvey, Jimmie H.; Arcasoy, Murat O.; Hexner, Elizabeth; Lyons, Roger M.; Paquette, Ronald; Raza, Azra; Vaddi, Kris; Erickson-Viitanen, Susan; Sun, William; Sandor, Victor; Kantarjian, Hagop M.

Book ID: 120350765
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 342 KB
Volume: 161
Category: Article
ISSN: 0007-1048
DOI: 10.1111/bjh.12274

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

7157 Subgroup analysis of French patient

7157 Subgroup analysis of French patients from RECORD-1: a randomized, placebo-controlled, phase III study of everolimus, a novel therapy for patients with metastatic renal cell carcinoma

✍ Ravaud, A.; Kay, A.; Lewohl, D. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Lanthanum carbonate versus placebo for m

Lanthanum carbonate versus placebo for management of hyperphosphatemia in patients undergoing peritoneal dialysis: a subgroup analysis of a phase 2 randomized controlled study of dialysis patients

✍ Alastair J Hutchison, Maggie Gill, J Brian Copley, Lynne Poole… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 173 KB

719 EVEROLIMUS IN PATIENTS WITH METASTAT

719 EVEROLIMUS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA: SUBGROUP ANALYSIS OF PATIENTS WITH A REDUCTION IN TUMOR BURDEN ENROLLED IN A RANDOMIZED, PLACEBO-CONTROLLED, PHASE II TRIAL

✍ S. Oudard; B. Escudier; T. Hutson; C. Porta; S. Bracarda; V. Grunwald; J. Thomps 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 194 KB

7136 Randomized, placebo-controlled, pha

7136 Randomized, placebo-controlled, phase 3 study of everolimus, a novel therapy for patients with metastatic renal cell carcinoma: subgroup analysis of patients progressing on prior bevacizumab therapy

✍ Hutson, T.; Negrier, S.; Kay, A. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Ustekinumab in patients with active psor

Ustekinumab in patients with active psoriatic arthritis: Results of the phase III, multicenter, double-blind, placebo-controlled PSUMMIT I study

📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Everolimus Plus Octreotide Long-Acting R

Everolimus Plus Octreotide Long-Acting Repeatable in Patients With Colorectal Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-2 Study

✍ Castellano, D.; Bajetta, E.; Panneerselvam, A.; Saletan, S.; Kocha, W.; O'Dorisi 📂 Article 📅 2012 🏛 Alphamed Press 🌐 English ⚖ 1019 KB